Post-stroke mortality, stroke severity, and preadmission antipsychotic medicine use--a population-based cohort study.
<h4>Background and purpose</h4>It has been suggested that antipsychotic medication may be neuroprotective and may reduce post-stroke mortality, but studies are few and ambiguous. We aimed to investigate the post-stroke effects of preadmission antipsychotic use.<h4>Methods</h4>...
Main Authors: | Anders Prior, Thomas Munk Laursen, Karen Kjær Larsen, Søren Paaske Johnsen, Jakob Christensen, Grethe Andersen, Mogens Vestergaard |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24416196/pdf/?tool=EBI |
Similar Items
-
The impact of preadmission oral bisphosphonate use on 30-day mortality following stroke: a population-based cohort study of 100,043 patients
by: Christensen DH, et al.
Published: (2015-08-01) -
Prevalence and impact of SARS-CoV-2 infection among patients with acute ischaemic stroke: a nationwide register-based cohort study in Denmark
by: Søren Paaske Johnsen, et al.
Published: (2024-03-01) -
Some questions about preadmission metformin use and mortality in patients with sepsis and diabetes mellitus
by: Jiarong Ye, et al.
Published: (2019-03-01) -
Risk and Subtypes of Stroke Following New‐Onset Postoperative Atrial Fibrillation in Coronary Bypass Surgery: A Population‐Based Cohort Study
by: Louise Feilberg Rasmussen, et al.
Published: (2022-12-01) -
Impact of prestroke physical activity and citalopram treatment on poststroke depressive symptoms: a secondary analysis of data from the TALOS randomised controlled trial in Denmark
by: Søren Paaske Johnsen, et al.
Published: (2023-03-01)